These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3757436)

  • 1. A simple method for definition of incomplete suppression of aldosterone and its association with hypertension and hypokalaemia in man.
    Adam WR
    Clin Sci (Lond); 1986 Oct; 71(4):375-83. PubMed ID: 3757436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia.
    Williams JS; Williams GH; Raji A; Jeunemaitre X; Brown NJ; Hopkins PN; Conlin PR
    J Hum Hypertens; 2006 Feb; 20(2):129-36. PubMed ID: 16292348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomograms relating aldosterone excretion to urinary sodium and potassium in the pediatric population: their application to the study of childhood hypertension.
    New MI; Baum CJ; Levine LS
    Am J Cardiol; 1976 Mar; 37(4):658-66. PubMed ID: 943925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deoxycorticosterone excretion in normal, hypertensive and hypokalaemic subjects.
    Cope CL; Loizou S
    Clin Sci Mol Med; 1975 Feb; 48(2):97-105. PubMed ID: 1167821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma uric acid concentration related to the urinary excretion of aldosterone and of electrolytes in normal subjects.
    Ramsay LE; Auty RM; Horth CE; Levine D; Shelton JR; Branch RA
    Clin Sci Mol Med; 1975 Dec; 49(6):613-6. PubMed ID: 1204292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial potassium loss and hypokalaemia during chlorthalidone administration in patients with essential hypertension: the influence of dietary sodium restriction.
    Landmann-Suter R; Struyvenberg A
    Eur J Clin Invest; 1978 Jun; 8(3):155-64. PubMed ID: 28952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity.
    Collins RD; Weinberger MH; Dowdy AJ; Nokes GW; Gonzales CM; Luetscher JA
    J Clin Invest; 1970 Jul; 49(7):1415-26. PubMed ID: 4317384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aldosterone excretion and plasma renin activity in patients with essential hypertension and with primary aldosteronism (author's transl)].
    Helber A; Meurer KA; Rosskamp E; Wambach G; Dickmans HA; Kaufmann W
    Klin Wochenschr; 1974 Oct; 52(20):966-73. PubMed ID: 4444216
    [No Abstract]   [Full Text] [Related]  

  • 9. Long term evolution of glucocorticoid-suppressible hyperaldosteronism.
    Stockigt JR; Scoggins BA
    J Clin Endocrinol Metab; 1987 Jan; 64(1):22-6. PubMed ID: 3536983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary kallikrein excretion in hypertensive man. Relationships to sodium intake and sodium-retaining steroids.
    Margolius HS; Horwitz D; Pisano JJ; Keiser HR
    Circ Res; 1974 Dec; 35(6):820-5. PubMed ID: 4430079
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal potassium wasting in distal renal tubular acidosis: role of aldosterone.
    Muto S; Asano Y; Okazaki H; Kano S
    Intern Med; 1992 Aug; 31(8):1047-51. PubMed ID: 1335804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Life-threatening hypokalaemia on a low-carbohydrate diet associated with previously undiagnosed primary hyperaldosteronism [corrected].
    Advani A; Taylor R
    Diabet Med; 2005 Nov; 22(11):1605-7. PubMed ID: 16241928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary kallikrein excretion in patients with primary aldosteronism: differentiation of adrenal adenoma from idiopathic adrenal hyperplasia.
    Nakada T
    Urol Int; 1984; 39(1):40-5. PubMed ID: 6375065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dietary potassium and race on urinary excretion of kallikrein and aldosterone in man.
    Horwitz D; Margolius HS; Keiser HR
    J Clin Endocrinol Metab; 1978 Aug; 47(2):296-9. PubMed ID: 263797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperaldosteronism after decreased renal K+ excretion in KCNMB2 knockout mice.
    Larsen CK; Jensen IS; Sorensen MV; de Bruijn PI; Bleich M; Praetorius HA; Leipziger J
    Am J Physiol Renal Physiol; 2016 May; 310(10):F1035-46. PubMed ID: 26962098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone excretion rate in normal subjects and hypertensive patients.
    Hsieh BS; Chen WY; Cheng JT; Yen TS
    Taiwan Yi Xue Hui Za Zhi; 1976 Jul; 75(7):382-91. PubMed ID: 1069093
    [No Abstract]   [Full Text] [Related]  

  • 17. Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance.
    Stowasser M; Bachmann AW; Huggard PR; Rossetti TR; Gordon RD
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2160-6. PubMed ID: 10852446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between insulin release, antinatriuresis and hypokalaemia after glucose ingestion in normal and hypertensive man.
    Natali A; Quiñones Galvan A; Santoro D; Pecori N; Taddei S; Salvetti A; Ferrannini E
    Clin Sci (Lond); 1993 Sep; 85(3):327-35. PubMed ID: 8403806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of glucocorticoid administration on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
    Newton MA; Laragh JH
    J Clin Endocrinol Metab; 1968 Jul; 28(7):1014-22. PubMed ID: 4298943
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diurnal variation in the urinary excretion of vanilmandelic acid and aldosterone in normal and hypertensive persons (author's transl)].
    Deck KA; Luedtke A; Eberlein L
    Klin Wochenschr; 1976 Feb; 54(3):131-5. PubMed ID: 1256000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.